Midbrain dopaminergic neurons in the mouse: Co-localization with calbindin-D(28K) and calretinin

C. L. Liang, C. M. Sinton, D. C. German

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

The calcium-binding proteins Calbindin-D(28k) and calretinin are co-localized with dopamine in some of the midbrain dopaminergic neurons in the rat and monkey; the present study sought to examine the pattern of co-localization in the mouse. Double immunofluorescence staining procedures were used for tyrosine hydroxylase (a dopaminergic cell marker) and Calbindin-D(28k) or calretinin. Midbrain dopaminergic neurons were examined at four rostrocaudal levels, and the percentage of cells that contained both tyrosine hydroxylase and either of the two calcium-binding proteins was determined in nucleus A8 (retrorubral field), nucleus A9 (substantia nigra pars compacta, pars reticulata and pars lateralis) and nucleus A10 (nucleus paranigralis, ventral tegmental area, interfascicular nucleus, central linear nucleus). The two calcium-binding proteins were distributed similarly in midbrain dopaminergic neurons in the several nuclear groups that comprise nuclei A8, A9 and A10. The calcium-binding proteins were found in the majority (50-100%) of nucleus A10 neurons, whereas in nuclei A8 and A9 (except for the substantia nigra pars lateralis) less than 40% of the cells contained either calcium-binding protein. The pattern of co-localization in the mouse is similar to that reported for the rat and monkey. The calcium-binding proteins mark the population of midbrain dopaminergic neurons that are less vulnerable to degeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Original languageEnglish (US)
Pages (from-to)523-533
Number of pages11
JournalNeuroscience
Volume75
Issue number2
DOIs
StatePublished - Oct 25 1996

Fingerprint

Calbindin 2
Calbindins
Calcium-Binding Proteins
Dopaminergic Neurons
Mesencephalon
antineoplaston A10
Tyrosine 3-Monooxygenase
Haplorhini
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Ventral Tegmental Area
Raphe Nuclei
Fluorescent Antibody Technique
Parkinson Disease
Dopamine
Staining and Labeling
Neurons
Population
Pars Reticulata

Keywords

  • calcium-binding proteins
  • immunoytochemistry
  • tyrosine hydroxylase

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Midbrain dopaminergic neurons in the mouse : Co-localization with calbindin-D(28K) and calretinin. / Liang, C. L.; Sinton, C. M.; German, D. C.

In: Neuroscience, Vol. 75, No. 2, 25.10.1996, p. 523-533.

Research output: Contribution to journalArticle

@article{4956bc94b27e4b1b9bd5aa9bf4d5a9b3,
title = "Midbrain dopaminergic neurons in the mouse: Co-localization with calbindin-D(28K) and calretinin",
abstract = "The calcium-binding proteins Calbindin-D(28k) and calretinin are co-localized with dopamine in some of the midbrain dopaminergic neurons in the rat and monkey; the present study sought to examine the pattern of co-localization in the mouse. Double immunofluorescence staining procedures were used for tyrosine hydroxylase (a dopaminergic cell marker) and Calbindin-D(28k) or calretinin. Midbrain dopaminergic neurons were examined at four rostrocaudal levels, and the percentage of cells that contained both tyrosine hydroxylase and either of the two calcium-binding proteins was determined in nucleus A8 (retrorubral field), nucleus A9 (substantia nigra pars compacta, pars reticulata and pars lateralis) and nucleus A10 (nucleus paranigralis, ventral tegmental area, interfascicular nucleus, central linear nucleus). The two calcium-binding proteins were distributed similarly in midbrain dopaminergic neurons in the several nuclear groups that comprise nuclei A8, A9 and A10. The calcium-binding proteins were found in the majority (50-100{\%}) of nucleus A10 neurons, whereas in nuclei A8 and A9 (except for the substantia nigra pars lateralis) less than 40{\%} of the cells contained either calcium-binding protein. The pattern of co-localization in the mouse is similar to that reported for the rat and monkey. The calcium-binding proteins mark the population of midbrain dopaminergic neurons that are less vulnerable to degeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.",
keywords = "calcium-binding proteins, immunoytochemistry, tyrosine hydroxylase",
author = "Liang, {C. L.} and Sinton, {C. M.} and German, {D. C.}",
year = "1996",
month = "10",
day = "25",
doi = "10.1016/0306-4522(96)00228-X",
language = "English (US)",
volume = "75",
pages = "523--533",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Midbrain dopaminergic neurons in the mouse

T2 - Co-localization with calbindin-D(28K) and calretinin

AU - Liang, C. L.

AU - Sinton, C. M.

AU - German, D. C.

PY - 1996/10/25

Y1 - 1996/10/25

N2 - The calcium-binding proteins Calbindin-D(28k) and calretinin are co-localized with dopamine in some of the midbrain dopaminergic neurons in the rat and monkey; the present study sought to examine the pattern of co-localization in the mouse. Double immunofluorescence staining procedures were used for tyrosine hydroxylase (a dopaminergic cell marker) and Calbindin-D(28k) or calretinin. Midbrain dopaminergic neurons were examined at four rostrocaudal levels, and the percentage of cells that contained both tyrosine hydroxylase and either of the two calcium-binding proteins was determined in nucleus A8 (retrorubral field), nucleus A9 (substantia nigra pars compacta, pars reticulata and pars lateralis) and nucleus A10 (nucleus paranigralis, ventral tegmental area, interfascicular nucleus, central linear nucleus). The two calcium-binding proteins were distributed similarly in midbrain dopaminergic neurons in the several nuclear groups that comprise nuclei A8, A9 and A10. The calcium-binding proteins were found in the majority (50-100%) of nucleus A10 neurons, whereas in nuclei A8 and A9 (except for the substantia nigra pars lateralis) less than 40% of the cells contained either calcium-binding protein. The pattern of co-localization in the mouse is similar to that reported for the rat and monkey. The calcium-binding proteins mark the population of midbrain dopaminergic neurons that are less vulnerable to degeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

AB - The calcium-binding proteins Calbindin-D(28k) and calretinin are co-localized with dopamine in some of the midbrain dopaminergic neurons in the rat and monkey; the present study sought to examine the pattern of co-localization in the mouse. Double immunofluorescence staining procedures were used for tyrosine hydroxylase (a dopaminergic cell marker) and Calbindin-D(28k) or calretinin. Midbrain dopaminergic neurons were examined at four rostrocaudal levels, and the percentage of cells that contained both tyrosine hydroxylase and either of the two calcium-binding proteins was determined in nucleus A8 (retrorubral field), nucleus A9 (substantia nigra pars compacta, pars reticulata and pars lateralis) and nucleus A10 (nucleus paranigralis, ventral tegmental area, interfascicular nucleus, central linear nucleus). The two calcium-binding proteins were distributed similarly in midbrain dopaminergic neurons in the several nuclear groups that comprise nuclei A8, A9 and A10. The calcium-binding proteins were found in the majority (50-100%) of nucleus A10 neurons, whereas in nuclei A8 and A9 (except for the substantia nigra pars lateralis) less than 40% of the cells contained either calcium-binding protein. The pattern of co-localization in the mouse is similar to that reported for the rat and monkey. The calcium-binding proteins mark the population of midbrain dopaminergic neurons that are less vulnerable to degeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

KW - calcium-binding proteins

KW - immunoytochemistry

KW - tyrosine hydroxylase

UR - http://www.scopus.com/inward/record.url?scp=0030601734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030601734&partnerID=8YFLogxK

U2 - 10.1016/0306-4522(96)00228-X

DO - 10.1016/0306-4522(96)00228-X

M3 - Article

C2 - 8931015

AN - SCOPUS:0030601734

VL - 75

SP - 523

EP - 533

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 2

ER -